March 20, 2018 / 11:34 AM / 7 months ago

BRIEF-Cipher Pharmaceuticals And Cardiome Pharma Announce Strategic Transaction For Canadian Business Portfolio Of Cardiome

March 20 (Reuters) - Cardiome Pharma Corp:

* CIPHER PHARMACEUTICALS AND CARDIOME PHARMA ANNOUNCE STRATEGIC TRANSACTION FOR CANADIAN BUSINESS PORTFOLIO OF CARDIOME

* CIPHER PHARMACEUTICALS INC - DEAL PROVIDES IMPORTANT UPFRONT AND NON-DILUTIVE CONSIDERATION OF $25.5 MILLION CAD

* CIPHER PHARMACEUTICALS - ‍PROPOSED DEAL TO BE COMPLETED PURSUANT TO ACQUISITION BY CIPHER OF ALL OF CARDIOME SHARES, FOLLOWING RESTRUCTURING OF CARDIOME​

* CIPHER PHARMACEUTICALS - ‍CARDIOME SHAREHOLDERS TO GET SHARES, ON A ONE-FOR-ONE RATIO, OF NEWLY CREATED CANADIAN ENTITY NAMED CORREVIO PHARMA

* CIPHER PHARMACEUTICALS INC - BOARD OF DIRECTORS OF CARDIOME HAS UNANIMOUSLY APPROVED ARRANGEMENT AGREEMENT

* CIPHER PHARMACEUTICALS INC - ‍EXPECTS TO FINANCE ACQUISITION WITH A COMBINATION OF CASH AND NEW DEBT​

* CIPHER PHARMACEUTICALS - ‍ALL OF DIRECTORS AND SENIOR OFFICERS OF CARDIOME HAVE ENTERED INTO VOTING AND SUPPORT AGREEMENTS WITH CIPHER​

* CIPHER PHARMACEUTICALS - VOTING AND SUPPORT AGREEMENTS’ BY ‍ALL OF DIRECTORS AND SENIOR OFFICERS OF CARDIOME IS TO VOTE IN FAVOUR OF ARRANGEMENT​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below